RNA-Based Therapy Utilizing Oculopharyngeal Muscular Dystrophy Transcript Knockdown and Replacement
Oculopharyngeal muscular dystrophy (OPMD) is caused by a small expansion of a short polyalanine (polyAla) tract in the poly(A)-binding protein nuclear 1 protein (PABPN1). Despite the monogenic nature of OPMD, no treatment is currently available. Here we report an RNA replacement strategy that has th...
Saved in:
Main Authors: | Aida Abu-Baker (Author), Nawwaf Kharma (Author), Jonathan Perreault (Author), Alanna Grant (Author), Masoud Shekarabi (Author), Claudia Maios (Author), Michele Dona (Author), Christian Neri (Author), Patrick A. Dion (Author), Alex Parker (Author), Luc Varin (Author), Guy A. Rouleau (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2019-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
BB-301: a silence and replace AAV-based vector for the treatment of oculopharyngeal muscular dystrophy
by: Vanessa Strings-Ufombah, et al.
Published: (2021) -
Inhibition of myostatin improves muscle atrophy in oculopharyngeal muscular dystrophy (OPMD)
by: Pradeep Harish, et al.
Published: (2019) -
Different outcomes of endurance and resistance exercise in skeletal muscles of Oculopharyngeal muscular dystrophy
by: Alexis Boulinguiez, et al.
Published: (2024) -
DNAJB6 isoform specific knockdown: Therapeutic potential for limb girdle muscular dystrophy D1
by: Andrew R. Findlay, et al.
Published: (2023) -
Oocyte-specific gene knockdown by intronic artificial microRNAs driven by Zp3 transcription in mice
by: Keisuke SASAKI, et al.
Published: (2021)